📊 The Week in Review
Markets ended the week deep in the red as Trump announced combat operations against Iran, sending the S&P 500 down 0.43% to 6,878.88, the Nasdaq tumbling 0.92% to 22,668.21, and the Dow dropping 1.05% to 48,977.92. Warren Buffett's final quarter as Berkshire CEO saw operating earnings crater 30%, while geopolitical chaos had oil tankers scrambling for safety in the Gulf.🔭 The Week Ahead
All eyes turn to how crude prices and defense stocks react to escalating Middle East tensions, with any signs of supply disruption likely to ripple through energy-heavy portfolios. Watch for Fed officials' commentary on whether geopolitical risk could delay rate cuts or fuel an inflation resurgence through the energy channel.
Have you heard the big news? Elon Musk’s company Starlink is preparing to announce their IPO as soon as March 26th! According to Quartz, “Elon Musk’s Starlink IPO may lift off any day now”. And for the first time ever, you have the rare chance to see how to profit BEFORE the IPO takes place.
Click here now for the time-sensitive details.
What do Buffett, Griffin, Koch, and 100+ members of Congress have in common? They're all betting on one overlooked $20 stock. It's in a sector set to impact $85 trillion globally.
Click here to get the ticker>>>
Med-X is moving toward a possible Nasdaq listing (ticker: MXRX) - and once that happens, the early window closes. Before Wall Street prices it in, Med-X has already generated $6.4M in sales, placed Nature-Cide on Amazon.com, Walmart.com, and Kroger.com, and begun expanding into 41+ global markets. Florida's mosquito control districts-America's most well-funded and influential-are independently testing Nature-Cide botanical pesticides, as Med-X pursues WHO pre-qualification for global public health adoption. This is the gap before the bell.
Review the Med-X opportunity now - before Nasdaq plans unfold.
Our analysts identified five stocks positioned for potential doubles: an industrial giant pivoting to AI with a $1.5B contract, a biotech awaiting FDA approval worth $60M, a gaming leader partnering with ESPN, an AI-cloud provider hiding a $60B backlog, and a newly-permitted U.S. gold developer.
Get the free report now.
While everyone else chases bullion, one income expert reveals a $15 gold fund that's been quietly paying up to 64% annually — month after month — as gold soars. The next payout is just days away.
Watch the Gold Income Briefing Now.